Evidence map›Paper›PMID 24211614›Full record

ArticleFree radical biology & medicine2014

Endothelin-1 stimulates catalase activity through the PKCδ-mediated phosphorylation of serine 167.

Ruslan Rafikov, Sanjiv Kumar, Saurabh Aggarwal, Yali Hou, Archana Kangath, Daniel Pardo, Jeffrey R Fineman, Stephen M Black

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cellular Pre-Adaptation to the High OAntioxidants (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Protective Effect of Nopal Cactus (International journal of molecular sciences · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Plant catalases as NO and HRedox biology · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ruslan RafikovPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Sanjiv KumarPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Saurabh AggarwalPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Yali HouPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Archana KangathPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Daniel PardoPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA.
Jeffrey R FinemanDepartment of Pediatrics, University of California at San Francisco, San Francisco, CA 94143, USA; Cardiovascular Research Institute, University of California at San Francisco, San Francisco, CA 94143, USA.
Stephen M BlackPulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA 30912, USA. Electronic address: sblack@gru.edu.
Georgia Regents Medical Center · USAugusta University · USUniversity of California, San Francisco · US

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORSR01HL061284 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FINEMAN, JEFFREY R · 1999 to 2016
$8.3M
PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENER01HL060190 · NHLBI · UNIVERSITY OF MONTANA · PI Stephen M Black · 1998 to 2026
$7.1M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
ROS in Pulmonary Hypertension: Role of ADMAR01HL067841 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2002 to 2011
$2.6M
NHLBI NIH HHS P01 HL101902NHLBI NIH HHS R01 HL060190NHLBI NIH HHS R01 HL061284NHLBI NIH HHS R01 HL067841NICHD NIH HHS T32 HD049303
6 · The paper itself

Abstract

Our previous studies have shown that endothelin-1 (ET-1) stimulates catalase activity in endothelial cells and in lambs with acute increases in pulmonary blood flow (PBF), without altering gene expression. The purpose of this study was to investigate the molecular mechanism by which this occurs. Exposing pulmonary arterial endothelial cells to ET-1 increased catalase activity and decreased cellular hydrogen peroxide (H2O2) levels. These changes correlated with an increase in serine-phosphorylated catalase. Using the inhibitory peptide δV1.1, this phosphorylation was shown to be protein kinase Cδ (PKCδ) dependent. Mass spectrometry identified serine 167 as the phosphorylation site. Site-directed mutagenesis was used to generate a phospho-mimic (S167D) catalase. Activity assays using recombinant protein purified from Escherichia coli or transiently transfected COS-7 cells demonstrated that S167D catalase had an increased ability to degrade H2O2 compared to the wild-type enzyme. Using a phospho-specific antibody, we were able to verify that pS167 catalase levels are modulated in lambs with acute increases in PBF in the presence and absence of the ET receptor antagonist tezosentan. S167 is located on the dimeric interface, suggesting it could be involved in regulating the formation of catalase tetramers. To evaluate this possibility we utilized analytical gel filtration to examine the multimeric structure of recombinant wild-type and S167D catalase. We found that recombinant wild-type catalase was present as a mixture of monomers and dimers, whereas S167D catalase was primarily tetrameric. Further, the incubation of wild-type catalase with PKCδ was sufficient to convert wild-type catalase into a tetrameric structure. In conclusion, this is the first report indicating that the phosphorylation of catalase regulates its multimeric structure and activity.

Indexed as

AnimalsCatalaseChlorocebus aethiopsCOS CellsEndothelial CellsEndothelin-1Escherichia coliGene ExpressionHydrogen PeroxideMutagenesis, Site-DirectedOxidation-ReductionPhosphorylationPrimary Cell CultureProtein Kinase C-deltaProtein Kinase InhibitorsProtein MultimerizationCatalaseEndothelin-1Hydrogen PeroxideProtein Kinase C-deltaProtein Kinase InhibitorsPyridinesRecombinant ProteinsSerineTetrazolestezosentanVasodilator AgentsCatalaseFree radicalsPhosphorylationPosttranslational regulation

Identifiers

PMID24211614
PMCPMC3945115
OpenAlexW2010648114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.